ArticleJAMA2025

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

Michail Ignatiadis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.